Total Payments
$16,340
2024 Payments
$1,538
Companies
46
Transactions
696
Medicare Patients
8,347
Medicare Billing
$611,522
Payment Breakdown by Category
Food & Beverage$14,035 (85.9%)
Other$1,500 (9.2%)
Travel$747.03 (4.6%)
Education$57.85 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,035 | 687 | 85.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 2 | 9.2% |
| Travel and Lodging | $747.03 | 2 | 4.6% |
| Education | $57.85 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,910 | 45 | $0 (2024) |
| Boston Scientific Corporation | $1,938 | 24 | $0 (2024) |
| Abbott Laboratories | $1,115 | 18 | $0 (2023) |
| Amgen Inc. | $1,109 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,059 | 72 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $949.04 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $897.04 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $776.83 | 37 | $0 (2024) |
| PFIZER INC. | $670.92 | 39 | $0 (2024) |
| Amarin Pharma Inc. | $614.62 | 40 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,538 | 68 | Medtronic, Inc. ($222.59) |
| 2023 | $1,779 | 75 | Abbott Laboratories ($301.20) |
| 2022 | $1,504 | 74 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($199.58) |
| 2021 | $1,497 | 67 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($225.68) |
| 2020 | $1,935 | 73 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($997.90) |
| 2019 | $2,110 | 77 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($976.46) |
| 2018 | $1,715 | 112 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($274.07) |
| 2017 | $4,262 | 150 | BOSTON SCIENTIFIC CORPORATION ($1,348) |
All Payment Transactions
696 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Coronary | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Not Applicable | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $46.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,008 | 3,099 | $1.2M | $145,789 |
| 2022 | 17 | 2,280 | 3,366 | $1.2M | $146,016 |
| 2021 | 17 | 2,111 | 3,165 | $953,342 | $171,392 |
| 2020 | 20 | 1,948 | 2,918 | $509,380 | $148,325 |
Total Patients
8,347
Total Services
12,548
Medicare Billing
$611,522
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 332 | 600 | $500,223 | $58,152 | 11.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 367 | $173,870 | $25,189 | 14.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 78 | $65,187 | $8,500 | 13.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 389 | 740 | $73,298 | $8,416 | 11.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 156 | 156 | $66,581 | $8,196 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $70,579 | $7,883 | 11.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 99 | 99 | $68,288 | $6,041 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 89 | $53,223 | $5,708 | 10.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 104 | 107 | $46,002 | $5,671 | 12.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 374 | 489 | $25,293 | $2,791 | 11.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $19,779 | $2,741 | 13.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 40 | $14,400 | $1,793 | 12.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 117 | 133 | $11,671 | $1,540 | 13.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 44 | 53 | $7,050 | $931.26 | 13.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 18 | $6,159 | $775.98 | 12.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 13 | 14 | $7,084 | $656.92 | 9.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 23 | $3,682 | $441.18 | 12.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 12 | 17 | $3,279 | $362.74 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 288 | 443 | $373,721 | $44,391 | 11.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 327 | $147,872 | $20,033 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 253 | $151,736 | $16,415 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $95,300 | $9,974 | 10.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 157 | 159 | $70,806 | $8,302 | 11.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 423 | 739 | $71,040 | $8,182 | 11.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 40 | $50,200 | $6,732 | 13.4% |
About Peter Lenchur, MD PHD
Peter Lenchur, MD PHD is a Interventional Cardiology healthcare provider based in Roselle, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457335309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Lenchur, MD PHD has received a total of $16,340 in payments from pharmaceutical and medical device companies, with $1,538 received in 2024. These payments were reported across 696 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,035).
As a Medicare-enrolled provider, Lenchur has provided services to 8,347 Medicare beneficiaries, totaling 12,548 services with total Medicare billing of $611,522. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Nuclear Medicine, Cardiovascular Disease
- Location Roselle, NJ
- Active Since 12/05/2005
- Last Updated 05/02/2024
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457335309
Products in Payments
- LifeVest (Device) $2,910
- GENERAL - THERAPIES (Device) $1,091
- XARELTO (Drug) $1,059
- ENTRESTO (Drug) $782.00
- ELIQUIS (Drug) $747.82
- Repatha (Biological) $623.12
- Vascepa (Drug) $614.62
- VERQUVO (Drug) $536.84
- Corlanor (Drug) $477.59
- FARXIGA (Drug) $406.07
- PRALUENT (Drug) $401.58
- JARDIANCE (Drug) $371.26
- BRILINTA (Drug) $366.69
- WATCHMAN (Device) $294.83
- ZONTIVITY (Drug) $247.82
- COREVALVE EVOLUT R (Device) $206.58
- CHANTIX (Drug) $176.66
- WATCHMAN FLX (Device) $175.84
- TherOx DS2 Console (Device) $174.55
- Mitra Clip system (Device) $168.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.